These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35633168)
1. Neurometabolic Alterations in Motor Neuron Disease: Insights from Magnetic Resonance Spectroscopy. Christidi F; Karavasilis E; Argyropoulos GD; Velonakis G; Zouvelou V; Murad A; Evdokimidis I; Rentzos M; Seimenis I; Bede P J Integr Neurosci; 2022 Apr; 21(3):87. PubMed ID: 35633168 [TBL] [Abstract][Full Text] [Related]
2. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease. van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409 [TBL] [Abstract][Full Text] [Related]
5. Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: A fully automatic investigation of the magnetic susceptibility in the precentral cortex. Contarino VE; Conte G; Morelli C; Trogu F; Scola E; Calloni SF; Sanmiguel Serpa LC; Liu C; Silani V; Triulzi F Eur J Radiol; 2020 Mar; 124():108815. PubMed ID: 31945675 [TBL] [Abstract][Full Text] [Related]
6. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease. Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320 [TBL] [Abstract][Full Text] [Related]
7. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study. Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033 [TBL] [Abstract][Full Text] [Related]
8. "Switchboard" malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis. Chipika RH; Finegan E; Li Hi Shing S; McKenna MC; Christidi F; Chang KM; Doherty MA; Hengeveld JC; Vajda A; Pender N; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O; Bede P Neuroimage Clin; 2020; 27():102300. PubMed ID: 32554322 [TBL] [Abstract][Full Text] [Related]
9. Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routine. Rocha AJ; Maia Júnior AC Arq Neuropsiquiatr; 2012 Jul; 70(7):532-9. PubMed ID: 22836461 [TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Chan S; Kaufmann P; Shungu DC; Mitsumoto H Neuroimaging Clin N Am; 2003 May; 13(2):307-26. PubMed ID: 13677809 [TBL] [Abstract][Full Text] [Related]
12. Propagation patterns in motor neuron diseases: Individual and phenotype-associated disease-burden trajectories across the UMN-LMN spectrum of MNDs. Tahedl M; Li Hi Shing S; Finegan E; Chipika RH; Lope J; Hardiman O; Bede P Neurobiol Aging; 2022 Jan; 109():78-87. PubMed ID: 34656922 [TBL] [Abstract][Full Text] [Related]
13. Muscle MRI in motor neuron diseases: a systematic review. Kriss A; Jenkins T Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):161-175. PubMed ID: 34151652 [No Abstract] [Full Text] [Related]
14. Multimodal structural MRI in the diagnosis of motor neuron diseases. Ferraro PM; Agosta F; Riva N; Copetti M; Spinelli EG; Falzone Y; Sorarù G; Comi G; Chiò A; Filippi M Neuroimage Clin; 2017; 16():240-247. PubMed ID: 28794983 [TBL] [Abstract][Full Text] [Related]
15. The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools. Bede P; Querin G; Pradat PF Curr Opin Neurol; 2018 Aug; 31(4):431-438. PubMed ID: 29750730 [TBL] [Abstract][Full Text] [Related]
16. Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. Ng L; Khan F; Young CA; Galea M Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011776. PubMed ID: 28072907 [TBL] [Abstract][Full Text] [Related]
17. Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy. Weerasekera A; Peeters R; Sima D; Dresselaers T; Sunaert S; De Vocht J; Claeys K; Van Huffel S; Van Damme P; Himmelreich U Brain Res; 2019 Sep; 1718():22-31. PubMed ID: 31002818 [TBL] [Abstract][Full Text] [Related]